Clinical Trials on Breast Cancer
Total 54121 results
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
Taiho Oncology, Inc.CompletedAdvanced Solid Tumors (Excluding Breast Cancer)United States
-
Instituto do Cancer do Estado de São PauloFundação Faculdade de MedicinaTerminatedLocally Advanced HER2-negative Breast CancerBrazil
-
Instituto do Cancer do Estado de São PauloFundação Faculdade de MedicinaTerminatedLocally Advanced HER2-positive Breast CancerBrazil
-
Pomeranian Medical University SzczecinMaria Sklodowska-Curie National Research Institute of Oncology; Regional Oncology...UnknownBRCA1 Mutation | Breast Cancer Invasive NosPoland
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHER2-positive Breast Cancer | Early-stage Breast Cancer | Adjuvant Treatment After Trastuzumab | RCB Classification 1-2 | NeratiniChina
-
Zagazig UniversityCompletedEarly Breast Cancer | Arm Lymphedema | Lymphatic Spread of Breast CancerEgypt
-
National Cancer Institute (NCI)CompletedBreast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerCanada
-
M.D. Anderson Cancer CenterRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
University of OttawaCanadian Institutes of Health Research (CIHR); Canadian Cancer Society (CCS)Not yet recruitingBreast Cancer Female | Physical Inactivity
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.; Corcept Therapeutics; Breast Cancer Research FoundationRecruitingMetastatic Breast CancerUnited States
-
Hongmei ZhengRecruitingEndocrine Therapy | Breast Cancer FemaleChina
-
Fudan UniversityRecruitingHER2 Positive Early Breast CancerChina
-
Zhejiang Cancer HospitalRecruitingHER2-positive Advanced Breast CancerChina
-
Henan Cancer HospitalQilu Pharmaceutical Co., Ltd.; Beijing Biostar Pharmaceuticals Co., Ltd.Not yet recruitingHER-2 Negative Breast Cancer
-
Hospices Civils de LyonNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)RecruitingEarly Stage Breast CancerUnited States
-
Spanish Breast Cancer Research GroupAECC_Asociación Española contra el CáncerRecruitingInvasive Breast Cancer Early StagesSpain
-
Polly A. Niravath, MDRecruitingBreast Cancer | Estrogen Receptor Positive Breast CancerUnited States
-
AstraZenecaCompletedAdvanced and Metastatic Breast CancerUnited States, United Kingdom
-
AstraZenecaActive, not recruitingHormone Receptor Positive Breast CancerCanada, Spain, United States, Romania, Taiwan, Italy, Brazil, Peru, Russian Federation, China, Czechia, Ukraine, South Africa, Japan, Poland, Mexico, United Kingdom, Argentina, Slovakia, Turkey
-
University Medical Center GroningenCompleted
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Early Breast CancerUnited States, Italy, Spain, Poland, Taiwan, Thailand, Canada, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, China, Saudi Arabia, Russian Federation, Bulgaria
-
Novartis PharmaceuticalsSuspendedEarly Breast CancerAustralia
-
AstraZenecaDaiichi Sankyo Company, Limited 3-5-1 Nihonbashihoncho, Chuo-ku, TokyoActive, not recruitingAdvanced or Metastatic Breast CancerUnited States, Belgium, Canada, Denmark, France, Italy, Spain, Hungary, Poland, Taiwan, Russian Federation, Germany, Korea, Republic of, Brazil, Japan, Mexico, United Kingdom, China, Israel, Austria, Australia, Saudi Arabia, Netherl... and more
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerUnited States, Spain, United Kingdom
-
University of Pittsburgh Medical CenterCompletedBreast Cancer | Estrogen-receptor-positive Breast CancerUnited States
-
Veru Inc.TerminatedMetastatic Breast CancerUnited States, Spain, Poland, Ukraine
-
Dantari, Inc.CompletedHER2-negative Metastatic Breast CancerUnited States
-
Novartis PharmaceuticalsAvailableHR+, HER2-, Advanced Breast Cancer
-
Luye Pharma Group Ltd.CompletedAdvanced Breast CancerChina
-
Henan Cancer HospitalActive, not recruiting
-
ARCAGY/ GINECO GROUPTerminatedFirst Line Metastatic Breast CancerFrance
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdTerminatedHER2-positive Metastatic Breast CancerChina
-
Spanish Breast Cancer Research GroupRoche Farma, S.ACompleted
-
Uppsala UniversityRigshospitalet, Denmark; University of Agder; Norwegian School of Sport Sciences and other collaboratorsActive, not recruitingBreast Cancer FemaleSweden
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingHER2 Positive Metastatic Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Queen Mary University of LondonHoffmann-La Roche; Asan Medical Center; Kliniken Essen-Mitte; MedSIRActive, not recruitingBreast Cancer | Estrogen Receptor-positive Breast CancerUnited Kingdom
-
Velindre NHS TrustAstraZeneca; Cardiff and Vale University Health Board; Covance; Cenduit LLCActive, not recruitingEstrogen Receptor Positive Breast CancerUnited Kingdom
-
Tianjin Medical University Cancer Institute and...CompletedPyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast CancerHER2-positive Advanced Breast CancerChina
-
University of Texas Southwestern Medical CenterUniversity of Pennsylvania; PfizerCompletedAdvanced Breast CancerUnited States
-
University of VirginiaWithdrawnBreast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
The Methodist Hospital Research InstituteMillennium Pharmaceuticals, Inc.CompletedEstrogen Receptor Positive Breast CancerUnited States
-
Puma Biotechnology, Inc.CompletedHER2+ Metastatic Breast Cancer (MBC)United States, Canada, Spain, Singapore, Korea, Republic of, Taiwan, United Kingdom, Israel, Australia, Japan, Hong Kong, Finland, Ireland, Italy, France, Portugal, Germany, Sweden, Belgium, Brazil, Czechia, Switzerland, Argentina, Au... and more
-
IRCCS San RaffaelePolitecnico di MilanoUnknownChemotherapy Effect | Breast Cancer FemaleItaly
-
Novartis PharmaceuticalsCompletedPost Menopausal Breast CancerTaiwan, Malaysia, Turkey, Australia, Korea, Republic of, Thailand, Jordan, India, Vietnam, Morocco, Tunisia, Indonesia, South Africa
-
Queen Mary University of LondonAstraZenecaUnknownEstrogen Receptor Positive Breast CancerSpain, United Kingdom, France, Portugal, Georgia, Korea, Republic of, Germany, Hungary, Romania
-
Jenny C. Chang, MDThe Methodist Hospital Research InstituteCompletedMetastatic Breast CancerUnited States
-
AHS Cancer Control AlbertaActive, not recruitingEstrogen Receptor Positive Breast CancerCanada